Experienced in Hyperparathyroidism

Dr. Kerem Ozer

Endocrinology
170 Deepwood Dr, Suite 104, 
Round Rock, TX 
Experienced in Hyperparathyroidism
170 Deepwood Dr, Suite 104, 
Round Rock, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Kerem Ozer is an Endocrinologist in Round Rock, Texas. Dr. Ozer is rated as an Experienced provider by MediFind in the treatment of Hyperparathyroidism. His top areas of expertise are Diabetic Ketoacidosis, Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), and Juvenile Primary Osteoporosis.

His clinical research consists of co-authoring 12 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Endocrinology
Licenses
Internal Medicine in TX
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
FirstCare
  • HMO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO

Locations

170 Deepwood Dr, Suite 104, Round Rock, TX 78681

Additional Areas of Focus

Dr. Ozer has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Hypoparathyroidism

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Efficacy and Safety of Tirzepatide Once Weekly in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight- Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-1)
Efficacy and Safety of Tirzepatide Once Weekly in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight- Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-1)
Enrollment Status: Completed
Publish Date: July 24, 2025
Intervention Type: Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
A Post- Approval Study to Evaluate the Long-term Safety and Effectiveness of the Eversense® Continuous Glucose Monitoring (CGM) System
A Post- Approval Study to Evaluate the Long-term Safety and Effectiveness of the Eversense® Continuous Glucose Monitoring (CGM) System
Enrollment Status: Completed
Publish Date: June 12, 2025
Intervention Type: Device
Study Phase: Not Applicable
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo After an Intensive Lifestyle Program in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double Blind, Placebo-Controlled Trial (SURMOUNT-3)
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo After an Intensive Lifestyle Program in Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double Blind, Placebo-Controlled Trial (SURMOUNT-3)
Enrollment Status: Completed
Publish Date: May 16, 2024
Intervention Type: Other, Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
A Randomized, Phase 3, Open-label Trial Comparing the Effect of the Addition of Tirzepatide Once Weekly Versus Insulin Lispro (U100) Three Times Daily in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin (SURPASS-6)
A Randomized, Phase 3, Open-label Trial Comparing the Effect of the Addition of Tirzepatide Once Weekly Versus Insulin Lispro (U100) Three Times Daily in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin (SURPASS-6)
Enrollment Status: Completed
Publish Date: November 02, 2023
Intervention Type: Drug
Study Drugs: Tirzepatide, Insulin Lispro, Insulin Glargine
Study Phase: Phase 3
A Phase 2, Randomized, Parallel, Open-Label Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Study Participants With Type 1 Diabetes Mellitus Previously Treated With Multiple Daily Injection Therapy
A Phase 2, Randomized, Parallel, Open-Label Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Study Participants With Type 1 Diabetes Mellitus Previously Treated With Multiple Daily Injection Therapy
Enrollment Status: Completed
Publish Date: October 27, 2022
Intervention Type: Drug
Study Drugs: LY3209590, Insulin Degludec
Study Phase: Phase 2
Post Approval Study for Non-Adjunctive Use of Dexcom G5 and G6 CGM System for Diabetes Management
Post Approval Study for Non-Adjunctive Use of Dexcom G5 and G6 CGM System for Diabetes Management
Enrollment Status: Unknown
Publish Date: September 21, 2021
Intervention Type: Device
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog in Adults With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog in Adults With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion
Enrollment Status: Completed
Publish Date: January 22, 2021
Intervention Type: Drug
Study Phase: Phase 3
User Experience and Daily Use Patterns With the Integrated Insulin Management (IIM) System
User Experience and Daily Use Patterns With the Integrated Insulin Management (IIM) System
Enrollment Status: Completed
Publish Date: January 07, 2021
Intervention Type: Drug, Device
Study Phase: Not Applicable
View 7 Less Clinical Trials

12 Total Publications

Embracing Generative Artificial Intelligence in Clinical Research and Beyond: Opportunities, Challenges, and Solutions.
Embracing Generative Artificial Intelligence in Clinical Research and Beyond: Opportunities, Challenges, and Solutions.
Journal: JACC. Advances
Published: September 05, 2024
Similar Doctors
Distinguished in Hyperparathyroidism
Dr. Shema R. Ahmad
Endocrinology
Distinguished in Hyperparathyroidism
Dr. Shema R. Ahmad
Endocrinology

Scott And White Clinic

2600 E Pflugerville Pkwy, 
Pflugerville, TX 
 (7.7 miles away)
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Shema Ahmad is an Endocrinologist in Pflugerville, Texas. Dr. Ahmad is rated as a Distinguished provider by MediFind in the treatment of Hyperparathyroidism. Her top areas of expertise are Hyperparathyroidism, Hyperthyroidism, Obesity in Children, and Thyroid Nodule.

Distinguished in Hyperparathyroidism
Dr. David Wenkert
Endocrinology
Distinguished in Hyperparathyroidism
Dr. David Wenkert
Endocrinology

Scott And White Clinic

810 W U Ave, 
Temple, TX 
 (44.1 miles away)
254-724-2585
Languages Spoken:
English
See accepted insurances

David Wenkert is an Endocrinologist in Temple, Texas. Dr. Wenkert is rated as a Distinguished provider by MediFind in the treatment of Hyperparathyroidism. His top areas of expertise are Sheehan Syndrome, Growth Hormone Deficiency (GHD), Kallmann Syndrome, and Pediatric Growth Hormone Deficiency.

Distinguished in Hyperparathyroidism
Dr. Anupama T. Reddy
Endocrinology
Distinguished in Hyperparathyroidism
Dr. Anupama T. Reddy
Endocrinology

Scott And White Clinic

1300 E Polk St, Baylor Scott And White Clini, 
Burnet, TX 
 (35.3 miles away)
512-715-6400
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Anupama Reddy is an Endocrinologist in Burnet, Texas. Dr. Reddy is rated as a Distinguished provider by MediFind in the treatment of Hyperparathyroidism. Her top areas of expertise are Diabetic Nephropathy, Diabetic Neuropathy, Hyperparathyroidism, and Obesity in Children.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ozer's expertise for a condition
ConditionClose
      View All 30 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile